These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 17266536

  • 1. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
    Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C, Prinssen EP.
    Curr Drug Targets; 2007 Jan; 8(1):117-35. PubMed ID: 17266536
    [Abstract] [Full Text] [Related]

  • 2. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM, Statnick MA, Rorick-Kehn LM, Pintar JE, Ansonoff M, Chen Y, Tucker RC, Ciccocioppo R.
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [Abstract] [Full Text] [Related]

  • 3. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R, Caló G, Lambert DG, Carrá G, Arduin M, Barnes TA, McDonald J, Rizzi D, Trapella C, Marzola E, Rowbotham DJ, Regoli D, Salvadori S.
    J Med Chem; 2005 Mar 10; 48(5):1421-7. PubMed ID: 15743186
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex.
    Mela F, Marti M, Ulazzi L, Vaccari E, Zucchini S, Trapella C, Salvadori S, Beani L, Bianchi C, Morari M.
    Eur J Neurosci; 2004 Mar 10; 19(5):1317-24. PubMed ID: 15016089
    [Abstract] [Full Text] [Related]

  • 5. UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor: radioligand and GTPgamma(35)S binding studies.
    McDonald J, Calo G, Guerrini R, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb 10; 367(2):183-7. PubMed ID: 12595960
    [Abstract] [Full Text] [Related]

  • 6. Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices.
    Kuo CJ, Liao YY, Guerrini R, Calo' G, Chiou LC.
    Eur J Pharmacol; 2008 Jan 28; 579(1-3):110-5. PubMed ID: 17976580
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray.
    Chiou LC, Fan SH, Chuang KC, Liao YY, Lee SZ.
    Ann N Y Acad Sci; 2004 Oct 28; 1025():398-403. PubMed ID: 15542742
    [Abstract] [Full Text] [Related]

  • 8. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.
    Ibba M, Kitayama M, McDonald J, Calo G, Guerrini R, Farkas J, Toth G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec 28; 378(6):553-61. PubMed ID: 18807245
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex.
    Marti M, Stocchi S, Paganini F, Mela F, De Risi C, Calo' G, Guerrini R, Barnes TA, Lambert DG, Beani L, Bianchi C, Morari M.
    Br J Pharmacol; 2003 Jan 28; 138(1):91-8. PubMed ID: 12522077
    [Abstract] [Full Text] [Related]

  • 10. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D.
    Br J Pharmacol; 2002 May 28; 136(2):303-11. PubMed ID: 12010780
    [Abstract] [Full Text] [Related]

  • 11. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G, Rizzi A, Guerrini R, Barnes TA, McDonald J, Hebbes CP, Mela F, Kenigs VA, Marzola G, Rizzi D, Gavioli E, Zucchini S, Regoli D, Morari M, Salvadori S, Rowbotham DJ, Lambert DG, Kapusta DR, Calo' G.
    J Pharmacol Exp Ther; 2005 Mar 28; 312(3):1114-23. PubMed ID: 15509719
    [Abstract] [Full Text] [Related]

  • 12. Effects of [(pF)Phe(4)]nociceptin/orphanin FQ-(1-13)NH(2) on GTPgamma(35)S binding and cAMP formation in Chinese hamster ovary cells expressing the human nociceptin/orphanin FQ receptor.
    McDonald J, Barnes TA, Calo G, Guerrini R, Rowbotham DJ, Lambert DG.
    Eur J Pharmacol; 2002 May 17; 443(1-3):7-12. PubMed ID: 12044785
    [Abstract] [Full Text] [Related]

  • 13. UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor.
    Calo' G, Rizzi A, Cifani C, Micioni Di Bonaventura MV, Regoli D, Massi M, Salvadori S, Lambert DG, Guerrini R.
    CNS Neurosci Ther; 2011 Jun 17; 17(3):178-98. PubMed ID: 20497197
    [Abstract] [Full Text] [Related]

  • 14. Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study.
    Linari G, Agostini S, Broccardo M, Petrella C, Improta G.
    Pharmacol Res; 2006 Nov 17; 54(5):356-60. PubMed ID: 16979347
    [Abstract] [Full Text] [Related]

  • 15. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
    Miller-Pérez C, Sánchez-Islas E, Pellicer F, Rodríguez-Manzo G, Cruz SL, León-Olea M.
    Eur J Pharmacol; 2008 Feb 26; 581(1-2):77-85. PubMed ID: 18096155
    [Abstract] [Full Text] [Related]

  • 16. 1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices.
    Liao YY, Trapella C, Chiou LC.
    Eur J Pharmacol; 2009 Mar 15; 606(1-3):84-9. PubMed ID: 19374842
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
    Zhang Y, Simpson-Durand CD, Standifer KM.
    Br J Pharmacol; 2015 Jan 15; 172(2):571-82. PubMed ID: 24666365
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids.
    Arduin M, Spagnolo B, Calò G, Guerrini R, Carrà G, Fischetti C, Trapella C, Marzola E, McDonald J, Lambert DG, Regoli D, Salvadori S.
    Bioorg Med Chem; 2007 Jul 01; 15(13):4434-43. PubMed ID: 17490886
    [Abstract] [Full Text] [Related]

  • 20. Structure-activity studies on different modifications of nociceptin/orphanin FQ: identification of highly potent agonists and antagonists of its receptor.
    Chang M, Peng YL, Dong SL, Han RW, Li W, Yang DJ, Chen Q, Wang R.
    Regul Pept; 2005 Sep 15; 130(3):116-22. PubMed ID: 15935490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.